Optimizing the therapeutic window of sirolimus by monitoring blood concentration for the treatment of immune thrombocytopenia
Yun Zhang(Kunming Institute of Zoology), Yimei Feng(Xinqiao Hospital), Jingkang Xiong(Army Medical University), Xi Zhang(Army Medical University), Quan Yao(Army Medical University), Shijie Yang(Army Medical University), Han Yao(Army Medical University), Xiaojuan Deng(Army Medical University), Wenhang Zou(Harbin Medical University), Kaniel Cassady(Regeneron (United States)), Dan Wang(Army Medical University), Ping Wang(Guangzhou Medical University)
Cited by 6
Related Papers
Recent advances in CAR-T cell engineering
|Journal of Hematology & Oncology|2020|403
Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma
|Cancer Cell|2020|234
Ambient Temperature and the Risk of Preterm Birth in Guangzhou, China (2001–2011)
|Environmental Health Perspectives|2015|169
TET2 Function in Hematopoietic Malignancies, Immune Regulation, and DNA Repair
|Frontiers in Oncology|2019|115
Strategies to enhance CAR-T persistence
|Biomarker Research|2022|90